Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era. [electronic resource]
Producer: 20100217Description: 561-76 p. digitalISSN:- 1744-7623
- Angioplasty, Balloon, Coronary
- Antineoplastic Agents, Phytogenic
- Coated Materials, Biocompatible
- Coronary Angiography -- methods
- Coronary Restenosis -- etiology
- Coronary Thrombosis -- prevention & control
- Drug-Eluting Stents -- trends
- Electrocardiography
- Graft Occlusion, Vascular -- prevention & control
- Humans
- Immunosuppressive Agents -- therapeutic use
- Meta-Analysis as Topic
- Myocardial Infarction -- prevention & control
- Platelet Aggregation Inhibitors -- adverse effects
- Prosthesis Design
- Registries
- Sirolimus -- adverse effects
- Stents -- adverse effects
- Treatment Outcome
- Tubulin Modulators -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.